SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-358412
Filing Date
2013-09-05
Accepted
2013-09-05 16:30:27
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d582671d10q.htm 10-Q 542726
2 EX-31.1 d582671dex311.htm EX-31.1 7650
3 EX-31.2 d582671dex312.htm EX-31.2 7662
4 EX-32.1 d582671dex321.htm EX-32.1 2801
5 EX-32.2 d582671dex322.htm EX-32.2 2810
  Complete submission text file 0001193125-13-358412.txt   5163071

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT agio-20130630.xml EX-101.INS 456483
7 XBRL TAXONOMY EXTENSION SCHEMA agio-20130630.xsd EX-101.SCH 36541
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agio-20130630_cal.xml EX-101.CAL 48701
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agio-20130630_def.xml EX-101.DEF 124319
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20130630_lab.xml EX-101.LAB 298072
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20130630_pre.xml EX-101.PRE 203208
Mailing Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-272-5275
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 131080718
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences